Quillen, K <br/><br/>
A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis.  [electronic resource] 

 -  Bone marrow transplantation  Jul 2011 
 - 976-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2010.239  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amyloidosis--drug therapy<br/>Cohort Studies<br/>Disease-Free Survival<br/>Female<br/>Hematopoietic Stem Cell Mobilization--methods<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Immunoglobulin Light-chain Amyloidosis<br/>Kaplan-Meier Estimate<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Recurrence<br/>Survival Analysis